CHROMID CANDIDA 43631

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05,06 report with the FDA on 2015-06-05 for CHROMID CANDIDA 43631 manufactured by Biom?rieux Sa.

Event Text Entries

[22720492] The customer reported lack of growth when testing a patient sample in conjunction with chromid candida agar (ref. 43631 - lot 1003875550 expiry 29-jun-2015) whereas microscopic examination of the concerned specimens revealed the presence of candida. The customer stated the same patient sample was inoculated via alternate method (rice agar) and growth of candida species, mostly c. Albicans, was observed following incubation. The customer stated that no false negative results were reported to a physician. The customer has not claimed any injury, death, unnecessary medical procedure or negative impact to the patient due to the chromid agar behavior. Patient isolate submittal has been requested. An internal biom? Rieux investigation has been initiated.
Patient Sequence No: 1, Text Type: D, B5


[39544107] The customer did not submit isolate strains for internal testing. The internal investigation was conducted using chromid candida retained samples of the same lot as that used by the customer (ref. (b)(4), lot 1003850260), and using the same strains as used during product release testing. All results were in accordance with specifications: good growth in 48 hours of candida albicans with characteristic blue colonies (atcc 2091 and atcc 10231). Good growth in 48 hours of candida tropicalis and candida kefyr with characteristic pink colonies (atcc 9968 and atcc 1162). Inhibited growth of other strains. Review of the associated manufacturing batch record confirmed no documented anomaly to explain the customer report of no growth of candida strain. The batch sterilization time and the results of the microbiological quality control were accordance with specifications. The issue reported by the customer could not be duplicated. The investigation concluded that the performance of chromid candida ref (b)(4), lot 1003850260 is within specification.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3002769706-2015-00039
MDR Report Key4821536
Report Source01,05,06
Date Received2015-06-05
Date of Report2015-05-12
Date of Event2015-04-30
Date Mfgr Received2015-05-12
Date Added to Maude2015-07-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMR. RYAN LEMELLE
Manufacturer Street595 ANGLUM ROAD
Manufacturer CityHAZELWOOD MO 63042
Manufacturer CountryUS
Manufacturer Postal63042
Manufacturer Phone3147318582
Manufacturer G1BIOM
Manufacturer Street595 ANGLUM ROAD
Manufacturer CityHAZELWOOD MO 63042
Manufacturer CountryUS
Manufacturer Postal Code63042
Single Use0
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCHROMID CANDIDA
Generic NameCHROMID CANDIDA AGAR
Product CodeJSI
Date Received2015-06-05
Catalog Number43631
Lot Number1003850260
Device Expiration Date2015-06-18
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerBIOM?RIEUX SA
Manufacturer Address5, RUE DES AQUEDUCS CRAPONNE, FR 69290 FR 69290


Patients

Patient NumberTreatmentOutcomeDate
10 2015-06-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.